Jonathan Pearce, who has more than 20 years’ experience leading UK charities including Lymphoma Action, has been appointed chief executive officer at Antibiotic Research UK.

He has also previously led blood cancer charity DKMS and chaired Cancer52, the membership organisation for rare and less common cancer charities.

Pearce has joined this month taking over from the charity’s founder Colin Garner, who retired in July.

“I was immediately drawn to the cause of Antibiotic Research UK with its focus on bringing about fundamental change while also delivering essential support services,” said Pearce.

“Increasingly, I have seen how cancer patients are left vulnerable as infections become resistant to existing antibiotics. And cancer is just one of many medical conditions that rely on antibiotics for treatments to be safe and effective. I have come to appreciate that tackling antibiotic resistance is one of the most urgent global health challenges of our time.

“I look forward to meeting all the incredible partners, volunteers, fundraisers, advocates and patients and their families involved in the work of this amazing charity. I am excited to bring my experience to bear on growing on the strong foundations already in place at Antibiotic Research UK.”

The charity’s chair Simon Dukes added “The entire Trustee Board recognised Jonathan as an exceptional candidate and voted unanimously to appoint him.

“During the selection process, Jonathan outlined a clear vision on how to build on the successes of Antibiotic Research UK thus far, and he demonstrated the skills to influence and lead the charity effectively in the future. We look forward to working with him.”

Share Story: